Extending palliative care to patients with Parkinson's disease

British Journal of Hospital Medicine

Volumn 71, Issue 1, 2010, Pages 26-30

  Wilcox, Sarah K ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE REPORT; FEMALE; HEALTH CARE DELIVERY; HUMAN; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PALLIATIVE THERAPY; PARKINSON DISEASE; PATIENT CARE PLANNING; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; TERMINAL CARE;

FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MIDDLE AGED; PALLIATIVE CARE; PARKINSON DISEASE; PATIENT CARE PLANNING; QUALITY OF LIFE; TERMINAL CARE;

EID: 77952297068     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2010.71.1.45969     Document Type: Article

References (20)

1. Barone JA (1999) Domperidone: a peripherally acting dopamine 2 receptor antagonist. Ann Pharmacother 33: 429-44.
2. Bunting-Perry LK (2006) Palliative care in Parkinsons disease: implications for neuroscience nursing. J Neurosci: Nurs 38(2): 106-13.
3. Calne SM, Kumar S (2003) Nursing care of patients with late stage Parkinson's disease.J Neurosci Nurs 35(5): 242-51.
4. Christie J, Bentley J, Magesh R (2007) The use of transdermal rotigotine in a patient with advanced Parkinson's disease and dysphagia. Palliat Med 21: 163-4.
5. De Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-35.
6. Goy ER, Carter JH, Ganzini L (2007) Parkinson's disease at the end of life: caregiver perspectives. Neurology 69(6): 611-12.
7. Goy ER, Carter JH, Ganzini L (2008) Needs and experiences of caregivers for family members. J Palliat care 24(2): 69-75.
8. Hoehn MM, Yahr MD (1967) Parkinsonism: Onset, progression and mortality. Neurology 17: 427-41.
9. Hudson PJ, Toye C, Kristjanson LJ (2006) Would people with Parkinson's disease benefit from palliative care? Palliat Med 20: 87-94.
10. Kristjanson LJ, Aoun SM, Oldham L (2005) Palliative care and support for people with neurodegenerative conditions and their carers. Int J Palliat Nurs 12(8): 368-77.
11. Lertxundi U, Peral J, Mora O, Domingo-Echabura S, Martinez-Bengoechea MJ, Garcia-Mongo JC (2008) Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease. Am J Health-Syst Pharm 65: 414-19.
12. MacMahon DC, Thomas S (1998) Practical approach to quality of life in Parkinson's disease. J Neurol 245(suppl 1): S19-22.
13. National Collaborating Centre for Chronic Conditions (2006) Parkinson's disease: national clinical guideline for diagnosis and management in primary and secondary care. Royal College ot Physicians, London (www.nice.org.uk/nicemedia/ pdf/cg035fullguideline.pdf accessed 23 November 2009).
14. Ramirez FC, Graham DY (1992) Treatment of intractable hiccup with baclofen: results of a double-blind randomized controlled cross-over study. Am J Gastroenterol 87: 1789-91.
15. Thomas S, MacMahon D (2004a) Parkinson's disease, palliative care and older people: part 1. Nurs Older People 16(1): 22-6.
16. Thomas S, MacMahon D (2004b) Parkinson's disease, palliative care and older people: part 2. Nurs Older People 16(2): 22-8.
17. Twycross R, Wilcock A (2002) Symptom Management in Advanced Cancer. 4th edn. Radcliffe Medical Press, Oxon.
18. Twycross R, Wilcock A, Charlesworth S, Dickman A (2007) Palliative Care Formulary, 3rd edn. Radcliffe Medical Press, Oxon.
19. Waters C (1997) Managing the late complications of Parkinson's disease. Neurology 49(suppl): S49-57.
20. Wilcox S, Garry A, Johnson M (2009) A novel use of amantadine: to treat hiccups. J Pain Symptom Manage 38(3): 460-5.